XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
REVENUE:    
Total revenue $ 1,539.7 $ 1,353.3
COST OF REVENUE:    
Total cost of revenue 293.1 304.7
GROSS PROFIT:    
Total gross profit 1,246.6 1,048.6
OPERATING EXPENSES:    
Research and development 198.6 173.0
Sales and marketing 542.7 501.1
General and administrative 57.8 54.4
Gain on intellectual property matters (6.3) (1.1)
Total operating expenses 792.8 727.4
OPERATING INCOME 453.8 321.2
INTEREST INCOME 44.3 32.2
INTEREST EXPENSE (4.9) (5.1)
OTHER INCOME (EXPENSE)—NET 26.1 (2.9)
INCOME BEFORE INCOME TAXES AND GAIN (LOSS) FROM EQUITY METHOD INVESTMENTS 519.3 345.4
PROVISION FOR INCOME TAXES 96.5 39.5
GAIN (LOSS) FROM EQUITY METHOD INVESTMENTS 10.6 (6.6)
NET INCOME $ 433.4 $ 299.3
Net income per share:    
Basic (in dollars per share) $ 0.56 $ 0.39
Diluted (in dollars per share) $ 0.56 $ 0.39
Weighted-average shares outstanding:    
Basic (in shares) 768.3 762.4
Diluted (in shares) 776.8 770.5
Product    
REVENUE:    
Total revenue $ 459.1 $ 408.9
COST OF REVENUE:    
Total cost of revenue 149.9 182.8
GROSS PROFIT:    
Total gross profit 309.2 226.1
Service    
REVENUE:    
Total revenue 1,080.6 944.4
COST OF REVENUE:    
Total cost of revenue 143.2 121.9
GROSS PROFIT:    
Total gross profit $ 937.4 $ 822.5